Atlas Therapeutics Shares Soar over 31% On Heavy Volume


Atlas Therapeutics Corp. (OTC: ATTH), the distributor and marketer of the world’s only clinically validated myostatin inhibitor, MYO-T12(R), announced the release of a new corporate video presentation by JB Bernstein, President and Chief Executive Officer of the Company.

In the video, Mr. Bernstein discusses the Company’s progress to date including its plan to create and distribute a full line of revolutionary nutritional supplements designed to maximize the results for people who wish to live “High-Performance Lifestyles.”

Atlas Therapeutics Corporation, formerly Marvin’s Place, Inc., is a development-stage company. It is focused on the formulation, acquisition and distribution of nutritional, nutraceutical, physical performance enhancement and wellness products.

The company increased 31.23% to $0.150 in Tuesday’s trading session.

Disclaimer:

The assembled information distributed by headlineotc.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Headlineotc.com does expect that investors will buy and sell securities based on information assembled and presented herein. Headlineotc.com will not be responsible in any way for or accept any liability for any losses arising from an investor’s reliance on or use of information obtained from our website or emails. PLEASE always do your own due diligence, and consult your financial adviser.

Our Research Report on ATTH is now available. Don´t Trade ATTH until you Read our FREE FULL REPORT. Click Here